| Year |
Citation |
Score |
| 2023 |
Sakemura RL, Hefazi M, Cox MJ, Siegler EL, Sinha S, Hansen MJ, Stewart CM, Feigin JM, Manriquez Roman C, Schick KJ, Can I, Tapper EE, Horvei P, Adada MM, Bezerra ED, ... ... Grand CL, et al. AXL inhibition improves the anti-tumor activity of chimeric antigen receptor T cells. Cancer Immunology Research. PMID 37378662 DOI: 10.1158/2326-6066.CIR-22-0254 |
0.503 |
|
| 2007 |
Olsen CE, Gourley ES, Lui X, Walker J, Grand CL, Warner SL, Vankayalapati H, Bearss DJ. Targeting the JAK2 Kinase in Hematological Malignancies. Blood. 110: 3560-3560. DOI: 10.1182/Blood.V110.11.3560.3560 |
0.556 |
|
| 2007 |
Gourley ES, Liu X, Lamb JD, Vankayalapati H, Grand CL, Bearss DJ. Targeting Pim Kinases in Hematological Malignancies. Blood. 110: 2655-2655. DOI: 10.1182/Blood.V110.11.2655.2655 |
0.49 |
|
| 2006 |
Grand C, Vankayalapati H, Liu X, Lamb J, Sunseri J, Lloyd M, Bearss D. 622 POSTER Discovery and characterization of a novel multi-targeted tyrosine kinase inhibitor with activity against c-ret, pdgfr, c-kit and c-src European Journal of Cancer Supplements. 4: 187-188. DOI: 10.1016/S1359-6349(06)70627-9 |
0.452 |
|
| 2006 |
Olsen C, Grand C, Vankayalapati H, Zhang X, Redman J, Sunseri J, Lloyd M, Bearss D. 415 POSTER Discovery and characterization of novel small molecule inhibitors of polo-like kinase-1, using a computational development process European Journal of Cancer Supplements. 4: 127. DOI: 10.1016/S1359-6349(06)70420-7 |
0.399 |
|
| 2006 |
Bearss D, Grand C, Lamb J, Lloyd M, Vankayalapati H. 414 POSTER Discovery and characterization of a small molecule inhibitor for pim-1 kinase European Journal of Cancer Supplements. 4: 127. DOI: 10.1016/S1359-6349(06)70419-0 |
0.41 |
|
| 2006 |
Grand C, Vankayalapati H, Lamb J, Bearss D. 413 POSTER Discovery and characterization of a series of Axl kinase inhibitors using the CLIMB process European Journal of Cancer Supplements. 4: 127. DOI: 10.1016/S1359-6349(06)70418-9 |
0.421 |
|
| 2006 |
Vankayalapati H, Grand C, Liu X, Zhang X, Lamb J, Lloyd M, Sunseri J, Bearss D. 341 POSTER The discovery of MP529, a potent and selective aurora kinase inhibitor using CLIMB European Journal of Cancer Supplements. 4: 106. DOI: 10.1016/S1359-6349(06)70346-9 |
0.419 |
|
| 2005 |
Grand CL, Powell TJ, Nagle RB, Bearss DJ, Tye D, Gleason-Guzman M, Hurley LH. Mutations in the G-quadruplex silencer element and their relationship to c-MYC overexpression, NM23 repression, and therapeutic rescue. Proceedings of the National Academy of Sciences of the United States of America. 102: 516. PMID 15696627 DOI: 10.1073/Pnas.0408999101 |
0.51 |
|
| 2004 |
Grand CL, Powell TJ, Nagle RB, Bearss DJ, Tye D, Gleason-Guzman M, Hurley LH. Mutations in the G-quadruplex silencer element and their relationship to c-MYC overexpression, NM23 repression, and therapeutic rescue. Proceedings of the National Academy of Sciences of the United States of America. 101: 6140-5. PMID 15079086 DOI: 10.1073/Pnas.0400460101 |
0.525 |
|
| 2004 |
Warner S, Vankayalapati H, Bashyam S, Grand C, Han H, Von Hoff D, Hurley L, Bearss D. 126 Development of a new series of tricyclic pyrimido-indole inhibitors targeting Aurora kinases European Journal of Cancer Supplements. 2: 41. DOI: 10.1016/S1359-6349(04)80134-4 |
0.525 |
|
| 2002 |
Grand CL, Han H, Muñoz RM, Weitman S, Von Hoff DD, Hurley LH, Bearss DJ. The cationic porphyrin TMPyP4 down-regulates c-MYC and human telomerase reverse transcriptase expression and inhibits tumor growth in vivo. Molecular Cancer Therapeutics. 1: 565-73. PMID 12479216 |
0.499 |
|
| 2002 |
Siddiqui-Jain A, Grand CL, Bearss DJ, Hurley LH. Direct evidence for a G-quadruplex in a promoter region and its targeting with a small molecule to repress c-MYC transcription. Proceedings of the National Academy of Sciences of the United States of America. 99: 11593-8. PMID 12195017 DOI: 10.1073/Pnas.182256799 |
0.515 |
|
| Show low-probability matches. |